Invokana Lawsuit Plaintiff Seeks $10 Million After Drug Allegedly Caused Development Of Diabetic Ketoacidosis

April 01, 2016 – – TheProductLawyers.com reports on another lawsuit which has been filed against new generation type-2 diabetes drug Invokana and manufacturer Janssen Pharmaceuticals (a division of Johnson & Johnson corporation). The plaintiff filing the complaint is a woman from Texas who claims that the defendant is responsible for the serious injuries she suffered, including a potentially life-threatening condition called diabetic ketoacidosis. Her lawsuit was filed in New Jersey, and she now requests over $10 million in compensatory pay for her injuries as well as past and future medical bills.

Details from court documents indicate that the plaintiff began taking Invokana in October of 2013 after being prescribed the drug by a physician to treat her type-2 diabetes. Invokana works by helping patients to manage their blood sugar (glucose) levels. To do this, the drug blocks the kidneys from reabsorbing excess sugar and instead uses them to remove that sugar from the body through urination.

The plaintiff claims that after taking Invokana for a short time, she suddenly suffered from serious injuries, including kidney damage and diabetic ketoacidosis. She states that her kidney damage is severe and irreparable, and maintains that when she realized she had developed these medical complications, she stopped all use of the drug only one month after starting it, in November of 2013.

Diabetic ketoacidosis is a condition that is caused when the body’s bloodstream develops excess toxic acid (ketones). It can cause patients to become comatose or even die if misdiagnosed or untreated. Both this condition and kidney damage have been linked to Invokana use among patients through adverse event reports to the U.S. Food and Drug Administration.

The attorneys of Banville Law understand how concerning these potential side effect links can be for patients currently using Invokana or other similar SGLT2 class inhibitor drugs. They are working to keep the public well-informed of the most recent information surrounding these drugs. To do so, they sponsor TheProductLawyers.com, an online resource for the general public. In addition, they are now working to assist patients who believe they have been negatively affected by the use of Invokana or similar drugs. The attorneys of Banville Law are working to ensure that affected patients will be provided with the important opportunity of exploring their legal rights in the matter. Those affected may be entitled to substantial compensation attained with legal action. To assist those interested in learning more, the attorneys of Banville Law are offering complimentary legal consultations for qualified parties at this time.

To request more information on Invokana lawsuits, or to ask questions, contact the attorneys of Banville Law by calling 877-671-6480.

###

Contact TheProductLawyers.com:

Banville Law
877-671-6480
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60009028